Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Searching for prostate cancer stem cells: markers and methods.

Sharpe B, Beresford M, Bowen R, Mitchard J, Chalmers AD.

Stem Cell Rev. 2013 Oct;9(5):721-30. doi: 10.1007/s12015-013-9453-4. Review.

PMID:
23775699
2.

Gene signatures distinguish stage-specific prostate cancer stem cells isolated from transgenic adenocarcinoma of the mouse prostate lesions and predict the malignancy of human tumors.

Mazzoleni S, Jachetti E, Morosini S, Grioni M, Piras IS, Pala M, Bulfone A, Freschi M, Bellone M, Galli R.

Stem Cells Transl Med. 2013 Sep;2(9):678-89. doi: 10.5966/sctm.2013-0041. Epub 2013 Jul 24.

3.

Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.

Nishida S, Hirohashi Y, Torigoe T, Kitamura H, Takahashi A, Masumori N, Tsukamoto T, Sato N.

J Urol. 2012 Jul;188(1):294-9. doi: 10.1016/j.juro.2012.02.2555. Epub 2012 May 16.

PMID:
22608744
4.

Revisiting the concept of cancer stem cells in prostate cancer.

Wang ZA, Shen MM.

Oncogene. 2011 Mar 17;30(11):1261-71. doi: 10.1038/onc.2010.530. Epub 2010 Nov 29. Review.

PMID:
21119602
5.

Activation of c-MET induces a stem-like phenotype in human prostate cancer.

van Leenders GJ, Sookhlall R, Teubel WJ, de Ridder CM, Reneman S, Sacchetti A, Vissers KJ, van Weerden W, Jenster G.

PLoS One. 2011;6(11):e26753. doi: 10.1371/journal.pone.0026753. Epub 2011 Nov 14.

6.

Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells.

Shimada K, Anai S, Fujii T, Tanaka N, Fujimoto K, Konishi N.

J Pathol. 2013 Dec;231(4):495-504. doi: 10.1002/path.4271.

PMID:
24549646
7.

Exploring the origins of the normal prostate and prostate cancer stem cell.

Kasper S.

Stem Cell Rev. 2008 Sep;4(3):193-201. doi: 10.1007/s12015-008-9033-1. Review. Erratum in: Stem Cell Rev. 2008 Dec;4(4):329.

PMID:
18563640
8.

DNA methylation markers for prostate cancer with a stem cell twist.

Jerónimo C, Esteller M.

Cancer Prev Res (Phila). 2010 Sep;3(9):1053-5. doi: 10.1158/1940-6207.CAPR-10-0131. Epub 2010 Aug 10.

9.
10.

MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.

Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ, Lee KH, Yeh SD, Hong TM, Chen YL.

Carcinogenesis. 2013 Mar;34(3):530-8. doi: 10.1093/carcin/bgs371. Epub 2012 Nov 26.

PMID:
23188675
11.

[Cancer stem cells in prostate cancer].

Nishida S, Masumori N.

Nihon Rinsho. 2014 Dec;72(12):2229-33. Review. Japanese.

PMID:
25518363
12.

Histone modifications, stem cells and prostate cancer.

Crea F, Clermont PL, Mai A, Helgason CD.

Curr Pharm Des. 2014;20(11):1687-97. Review.

PMID:
23888964
13.

Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line.

Rowehl RA, Crawford H, Dufour A, Ju J, Botchkina GI.

Cancer Genomics Proteomics. 2008 Nov-Dec;5(6):301-10.

14.

Epithelial stem cells of the prostate and their role in cancer progression.

Lukacs RU, Lawson DA, Xin L, Zong Y, Garraway I, Goldstein AS, Memarzadeh S, Witte ON.

Cold Spring Harb Symp Quant Biol. 2008;73:491-502. doi: 10.1101/sqb.2008.73.012. Epub 2008 Nov 6. Review.

PMID:
19022743
15.

Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastases.

Colombel M, Eaton CL, Hamdy F, Ricci E, van der Pluijm G, Cecchini M, Mege-Lechevallier F, Clezardin P, Thalmann G.

Prostate. 2012 May 15;72(7):713-20. doi: 10.1002/pros.21473. Epub 2011 Aug 31.

PMID:
21882211
16.

Do cancer cells undergo phenotypic switching? The case for imperfect cancer stem cell markers.

Zapperi S, La Porta CA.

Sci Rep. 2012;2:441. doi: 10.1038/srep00441. Epub 2012 Jun 7.

17.

Molecular signature of cancer stem cells isolated from prostate carcinoma and expression of stem markers in different Gleason grades and metastasis.

Castellón EA, Valenzuela R, Lillo J, Castillo V, Contreras HR, Gallegos I, Mercado A, Huidobro C.

Biol Res. 2012;45(3):297-305. doi: 10.4067/S0716-97602012000300011.

18.

Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.

Mosca E, Cocola C, Sabour D, Pelucchi P, Bertalot G, Palumbo O, Carella M, Götte M, Schöler HR, Reinbold R, Zucchi I, Milanesi L.

In Silico Biol. 2010;10(5-6):207-21. doi: 10.3233/ISB-2010-0437.

PMID:
22430355
19.

Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression.

Shukla S, Sharma H, Abbas A, MacLennan GT, Fu P, Danielpour D, Gupta S.

PLoS One. 2013;8(1):e53527. doi: 10.1371/journal.pone.0053527. Epub 2013 Jan 7.

20.

Cancer stem cells and markers: new model of tumorigenesis with therapeutic implications.

Natarajan TG, Ganesan N, Fitzgerald KT.

Cancer Biomark. 2010;9(1-6):65-99. doi: 10.3233/CBM-2011-0173. Review.

PMID:
22112470

Supplemental Content

Support Center